General Information

We will seek to identify, through the experience and expertise of our management team and board of directors, a biotech company that has demonstrated success and is primed to thrive in the rapidly evolving biotech industry.

Our co-sponsor, Chardan Monterey, is affiliated with Chardan Capital Markets, LLC, or Chardan, an investment firm and a provider of investment banking services, primarily focused on private and public emerging companies in the healthcare industry. Since its inception, Chardan has executed more than 500 equity capital markets transactions, raising approximately $26 billion of capital in both public and private markets. Chardan is a leading SPAC underwriter, SPAC sponsor (or co-sponsor) and SPAC M&A advisor, providing a highly competitive position as SPACs have become more accepted in the financial industry. Since 2004, Chardan has been the lead or co-lead underwriter on over 90 SPAC initial public offerings, as of September 2021. Chardan has sponsored or co-sponsored 13 SPACs with 7 successfully closed across multiple industries, 1 announced merger, 4 still in market, and 1 publicly filed. Chardan-advised SPACs have targeted a wide range of industries, including life sciences, healthcare services, technology hardware and software. No SPAC that has either been advised by Chardan or for which Chardan served as the lead underwriter has liquidated to date. Chardan has underwritten or advised over a dozen biotech focused SPACs. Since 2015, Chardan has met with private healthcare companies and has earned a reputation for partnering with innovative healthcare platforms to develop and deploy disruptive technologies.

(Note: Monterey Bio Acquisition Corp. priced its SPAC IPO on Sept. 30, 2021, in line with the terms in its prospectus: 10 million units at $10 each to raise $100 million.)


Employees: 0
Founded: 2020
Contact Information
Address 17 State Street 21st Floor New York, NY 10004
Phone Number (917) 267-0216
Web Address
Financial Information
Market Cap $125.0mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol MTRYU
Exchange NASDAQ
Shares (millions): 10.0
Price range $10.00 - $10.00
Est. $ Volume $100.0 mil
Manager / Joint Managers Chardan
CO-Managers -
Expected To Trade: 10/1/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change